| Issue Date | Title | Author(s) |
| 2019 | ALBUMIN AND PLATELET AFTER SIX MONTHS OF ANTIVIRAL THERAPY ARE INDEPENDENT SERUM MARKERS TO PREDICT LIVER RELATED EVENTS IN HBV-RELATED COMPENSATED LIVER CIRRHOSIS | Wu, Xiaoning; Zhou, Jialing; Meng, Tongtong; Sun, Yameng; Wang, Bingqiong; Piao, Hongxin; Ding, Huiguo; Xu, Xiaoyuan; Jiang, Wei; Chen, Yongpeng; Xie, Wen; Ma, Anlin; Cheng, Jun, Sr.; Cheng, Jilin; Zhang, Mingxiang; Guan, Qiushuang; Chen, Shuyan; Shi, Yiwen; Duan, Weijia; Kong, Yuanyuan; Ou, Xiaojuan; You, Hong; Jia, Jidong |
| Nov-2020 | ANTIVIRAL THERAPY IMPROVES LONG-TERM HEALTH RELATED QUALITY OF LIFE IN COMPENSATED HBV-CIRRHOSIS PATIENTS | Wu, Xiaoning; Hong, Jia; Zhou, Jialing; Sun, Yameng; Ding, Huiguo; Xie, Wen; Piao, Hongxin; Xu, Xiaoyuan; Jiang, Wei; Feng, Bo; Xu, Mingyi; Cheng, Jilin; Ou, Xiaojuan; Jia, Jidong; You, Hong |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| Mar-2020 | China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B | Shan, Shan; Wei, Wei; Kong, Yuanyuan; Niu, Junqi; Shang, Jia; Xie, Wen; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Nan, Yuemin; Dou, Xiaoguang; Han, Tao; Xu, Xiaoyuan; Duan, Zhongping; Wei, Lai; Hou, Jinlin; Zhuang, Hui; You, Hong; Jia, Jidong |
| 2019 | Chinese guidelines on the management of ascites and its related complications in cirrhosis | Xu, Xiaoyuan; Duan, Zhongping; Ding, Huiguo; Li, Wengang; Jia, Jidong; Wei, Lai; Linghu, Enqiang; Zhuang, Hui |
| 9-Jul-2024 | Chinese guidelines on the management of ascites in cirrhosis Chinese Society of Hepatology, Chinese Medical Association | Xu, Xiaoyuan; Ding, Huiguo; Jia, Jidong; Wei, Lai; Duan, Zhongping; Tang, Chengwei; Linghu, Enqiang; Nan, Yuemin; Han, Ying; Xu, Jinghang; Zhuang, Hui |
| 17-Feb-2025 | Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024) | Xu, Xiaoyuan; Ding, Huiguo; Li, Wengang; Han, Ying; Guan, Yujuan; Xu, Jinghang; Han, Yifan; Jia, Jidong; Wei, Lai; Duan, Zhongping; Nan, Yuemin; Zhuang, Hui; Chinese Society Hepatology; Chinese Medical Association |
| 2023 | Correlation between hepatic venous pressure gradient and portal pressure gradient in patients with autoimmune cirrhotic portal hypertension and collateral branches of the hepatic vein | Liu, Bowen; Zhang, Dan; Dong, Chengbin; Yue, Zhendong; Wang, Lei; Fan, Zhenhua; Wu, Yifan; Zhang, Ke; Jiang, Li; Ding, Huiguo; Zhang, Yuening; Wang, Jian; Liu, Fuquan |
| 2019 | Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir | Kong, Yuanyuan; Sun, Yameng; Zhou, Dialing; Wu, Xiaoning; Chen, Yongpeng; Piao, Hongxin; Lu, Lungen; Ding, Huiguo; Nan, Yuemin; Jiang, Wei; Xu, Youqing; Xie, Wen; Li, Hanwei; Feng, Bo; Shi, Guangfeng; Chen, Guofeng; Li, Hai; Zheng, Huanwei; Cheng, Jilin; Wang, Tailing; Liu, Hui; Lv, Fudong; Shao, Chen; Mao, Yimin; Sun, Jihong; Chen, Tao; Han, Tao; Han, Ying; Wan, Lin; Ou, Xiaojuan; Zhang, Hui; Jia, Jidong; You, Hong |
| 2019 | Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study | Wu, Xiaoning; Zhou, Jialing; Xie, Wen; Ding, Huiguo; Ou, Xiaojuan; Chen, Guofeng; Ma, Anlin; Xu, Xiaoyuan; Ma, Hui; Xu, Youqing; Liu, Xiaoqing; Meng, Tongtong; Wang, Lin; Sun, Yameng; Wang, Bingqiong; Kong, Yuanyuan; Ma, Hong; You, Hong; Jia, Jidong |
| 2016 | Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B | You, Hong; Kong, Yuanyuan; Hou, Jinlin; Wei, Lai; Zhang, Yuexin; Niu, Junqi; Han, Tao; Ou, Xiaojuan; Dou, Xiaoguang; Shang, Jia; Tang, Hong; Xie, Qing; Ding, Huiguo; Ren, Hong; Xu, Xiaoyuan; Xie, Wen; Liu, Xiaoqing; Xu, Youqing; Li, Yujie; Li, Jie; Chow, Shein-Chung; Zhuang, Hui; Jia, Jidong |
| 2016 | HBsAg and HBeAg in the prediction of a clinical response to peginterferon alpha-2b therapy in Chinese HBeAg-positive patients | Yang, Song; Xing, Huichun; Wang, Yuming; Hou, Jinlin; Luo, Duande; Xie, Qing; Ning, Qin; Ren, Hong; Ding, Huiguo; Sheng, Jifang; Wei, Lai; Chen, Shijun; Fan, Xiaoling; Huang, Wenxiang; Pan, Chen; Gao, Zhiliang; Zhang, Jiming; Zhou, Boping; Chen, Guofeng; Wan, Mobin; Tang, Hong; Wang, Guiqiang; Yang, Yuxiu; Xu, Dongping; Dong, Peiling; Wang, Qixin; Wang, Jue; Bognar, Fernando A.; Xu, Daozhen; Cheng, Jun |
| 2008 | Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors | Peng, Dandan; Han, Ying; Ding, Huiguo; Wei, Lai |
| 2017 | New Classification of Liver Biopsy Assessment for Fibrosis in Chronic Hepatitis B Patients Before and After Treatment | Sun, Yameng; Zhou, Jialing; Wang, Lin; Wu, Xiaoning; Chen, Yongpeng; Piao, Hongxin; Lu, Lungen; Jiang, Wei; Xu, Youqing; Feng, Bo; Nan, Yuemin; Xie, Wen; Chen, Guofeng; Zheng, Huanwei; Li, Hai; Ding, Huiguo; Liu, Hui; Lv, Fudong; Shao, Chen; Wang, Tailing; Ou, Xiaojuan; Wang, Bingqiong; Chen, Shuyan; Wee, Aileen; Theise, Neil D.; You, Hong; Jia, Jidong |
| 2019 | On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon alpha add-on therapy | Liu, Tianhui; Sun, Yameng; Zhou, Jialing; Yang, Fang; Zou, Xia; Wang, Lin; Wu, Xiaoning; Chen, Yongpeng; Piao, Hongxin; Lu, Lungen; Jiang, Wei; Xu, Youqing; Feng, Bo; Nan, Yuemin; Xie, Wen; Chen, Guofeng; Zheng, Huanwei; Li, Hai; Ding, Huiguo; Liu, Hui; Wang, Tailing; Ou, Xiaojuan; Wu, Shanshan; Kong, Yuanyuan; Wang, Ping; Cong, Min; Zhang, Yan; You, Hong; Jia, Jidong |
| 2014 | Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial | Cheng, Jun; Wang, Yuming; Hou, Jinlin; Luo, Duande; Xie, Qing; Ning, Qin; Ren, Hong; Ding, Huiguo; Sheng, Jifang; Wei, Lai; Chen, Shijun; Fan, Xiaoling; Huang, Wenxiang; Pan, Chen; Gao, Zhiliang; Zhang, Jiming; Zhou, Boping; Chen, Guofeng; Wan, Mobin; Tang, Hong; Wang, Guiqiang; Yang, Yuxiu; Mohamed, Rosmawati; Guan, Richard; Lee, Tzong-Hsi; Chang, Wen-Hsiung; Huang Zhenfei; Ye, Zhang; Xu, Daozhen |
| Oct-2022 | Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus beta-blocker | Chen, Yan; Ma, Xuemei; Zhang, Xuefeng; Luo, Jing; An, Linjing; Zhang, Yu; Chang, Xiujuan; Dong, Zheng; Zhang, Wei; Kong, Huifang; Zhao, Jun; Ding, Huiguo; Liu, Fuquan; Yang, Yongping |
| 2019 | Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China | Sun, Jian; Ding, Huiguo; Chen, Guofeng; Wang, Guiqiang; Wei, Lai; Zhang, Jiming; Xie, Qing; Wan, Mobin; Tang, Hong; Chen, Shijun; Gao, Zhiliang; Wang, Yuming; Zhang, Dazhi; Huang, Wenxiang; Sheng, Jifang; Ning, Qin; Yang, Dongliang; Lu, Jian; Pan, Chen; Yang, Yuxiu; Wang, Jue; Sun, Chuanzhen; Wang, Qixin; Hou, Jinlin |
